Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2012

Jun 5, 2012

31971_dirs_2012-06-05_2220fb69-d57b-40e6-a163-dcbb84a1d481.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-06-01

Reporting Person: Cohen Heather L (VP CORP HR&DEPUTY GEN COUNSEL)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-06-01 Common Stock M 200 Acquired 4253 Direct
2012-06-01 Common Stock F 73 $26.09 Disposed 4180 Direct
2012-06-01 Common Stock M 800 Acquired 4980 Direct
2012-06-01 Common Stock F 290 $26.09 Disposed 4690 Direct
2012-06-01 Common Stock M 800 Acquired 5490 Direct
2012-06-01 Common Stock F 290 $26.09 Disposed 5200 Direct
2012-06-01 Common Stock M 800 Acquired 6000 Direct
2012-06-01 Common Stock F 290 $26.09 Disposed 5710 Direct
2012-06-02 Common Stock M 600 Acquired 6310 Direct
2012-06-02 Common Stock F 218 $26.09 Disposed 6092 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-06-01 Rsus (restricted Stock Units) $0 M 200 Disposed 2018-06-01 Common Stock (200) Direct
2012-06-01 Rsus (restricted Stock Units) $0 M 800 Disposed 2019-06-01 Common Stock (800) Direct
2012-06-01 Rsus (restricted Stock Units) $0 M 800 Disposed 2020-06-01 Common Stock (800) Direct
2012-06-01 Rsus (restricted Stock Units) $0 M 800 Disposed 2021-06-01 Common Stock (800) Direct
2012-06-01 Rsus (restricted Stock Units) $0 A 4000 Acquired 2022-06-01 Common Stock (4000) Direct
2012-06-01 Sars (Stock Appreciation Rights) $26.09 A 10000 Acquired 2022-06-01 Common Stock (10000) Direct
2012-06-02 Rsus (restricted Stock Units) $0 M 600 Disposed 2018-06-02 Common Stock (600) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock
Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year
after the grant date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.